Outcomes and Risk Factors in Patients with Multiple Primary Melanomas.

[1]  S. Menzies,et al.  Multiple primary melanoma: a single centre retrospective review , 2017, Melanoma research.

[2]  Jeffrey E Gershenwald,et al.  Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.

[3]  H. Olsson,et al.  Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status , 2017, Journal of the American Academy of Dermatology.

[4]  Christine S. M. Lau,et al.  Malignant Melanoma in African–Americans , 2017, Medicine.

[5]  I. Soerjomataram,et al.  Comparing survival of patients with single or multiple primary melanoma in the Netherlands: 1994–2009 , 2017, The British journal of dermatology.

[6]  M. Asgari.  Utility and Limitations of Large Population-Based Data for Skin Cancer Outcomes. , 2016, The Journal of investigative dermatology.

[7]  J. Barnholtz-Sloan,et al.  Racial disparities in melanoma survival. , 2016, Journal of the American Academy of Dermatology.

[8]  H. Soyer,et al.  Ten-Year Survival after Multiple Invasive Melanomas Is Worse than after a Single Melanoma: a Population-Based Study. , 2016, The Journal of investigative dermatology.

[9]  D. Whiteman,et al.  The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031. , 2016, The Journal of investigative dermatology.

[10]  P. Ascierto,et al.  Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup. , 2016, Journal of the American Academy of Dermatology.

[11]  M. Coleman,et al.  The effect of multiple primary rules on cancer incidence rates and trends , 2016, Cancer Causes & Control.

[12]  N. Hayward,et al.  Survival outcomes in patients with multiple primary melanomas , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[13]  E. M. Warton,et al.  Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011. , 2015, Journal of the American Academy of Dermatology.

[14]  Maria L. Wei,et al.  Sex disparities in melanoma outcomes: the role of biology. , 2014, Archives of biochemistry and biophysics.

[15]  J. Coebergh,et al.  Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015 , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[16]  S. Rosso,et al.  Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study. , 2013, JAMA dermatology.

[17]  J. Lortet-Tieulent,et al.  International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? , 2013, International journal of cancer.

[18]  A. Stromberg,et al.  Second Primary Melanomas: Incidence and Outcome , 2010, The American surgeon.

[19]  S. Swetter,et al.  Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study. , 2010, Journal of the American Academy of Dermatology.

[20]  Samy Suissa,et al.  Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes , 2010, BMJ : British Medical Journal.

[21]  Myles G Cockburn,et al.  Increasing burden of melanoma in the United States. , 2009, The Journal of investigative dermatology.

[22]  P. Visscher,et al.  Geographical structure and differential natural selection among North European populations. , 2009, Genome research.

[23]  C. Garbe,et al.  Age and gender are significant independent predictors of survival in primary cutaneous melanoma , 2008, Cancer.

[24]  M. Berwick,et al.  Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. , 2008, Archives of dermatology.

[25]  S. Menzies,et al.  Enhanced survival in patients with multiple primary melanoma. , 2003, Archives of dermatology.

[26]  G. Mann,et al.  CDKN2A (P16INK4a) and CDK4 mutation analysis in 131 Australian melanoma probands: Effect of family history and multiple primary melanomas , 1999, Genes, chromosomes & cancer.

[27]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[28]  M. Tucker,et al.  CDKN2A mutations in multiple primary melanomas. , 1998, The New England journal of medicine.

[29]  S. Franceschi,et al.  Risk of cutaneous melanoma associated with a family history of the disease , 1995, International journal of cancer.

[30]  C. Slingluff,et al.  Multiple primary melanoma: incidence and risk factors in 283 patients. , 1993, Surgery.

[31]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[32]  W. Clark,et al.  Multiple primary melanoma , 1979, Cancer.

[33]  Melissa F. Weiner.  The Demography of Race and Ethnicity in The Netherlands: An Ambiguous History of Tolerance and Conflict , 2015 .

[34]  J. Zell,et al.  Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.